DHEA (dehydroepiandersterone), a
non-prescription dietary supplement, may be an effective treatment for
midlife-onset major and minor depression. Sexual functioning scores relative
to baseline were also improved.
Dehydroepiandrosterone
Monotherapy in Midlife-Onset Major and Minor Depression
Study Design: A double-blind, randomized, placebo-controlled, with
crossover treatment was conducted at The National Institutes of Mental
Health Midlife Outpatient Clinic in the National Institute of Health
Clinical Center, Bethesda MD, USA. 23 men and 23 women in aged 45 to 65
years with midlife-onset major or minor depression was given six weeks of
DHEA therapy, 90 mg per day for 3 weeks and 450 mg per day for 3 weeks, and
6 weeks of placebo.
Results Six weeks
of DHEA administration was associated with a significant improvement in the
17-Item Hamilton Depression Rating Scale and the Center for Epidemiologic
Studies Depression Scale ratings compared with both baseline (P<.01) and 6
weeks of placebo treatment (P<.01). A 50% or greater reduction in baseline
Hamilton Depression Rating Scale scores was observed in 23 subjects after
DHEA and in 13 subjects after placebo treatments. Six weeks of DHEA
treatment also was associated with significant improvements in Derogatis
Interview for Sexual Functioning scores relative to baseline and placebo
conditions.
Conclusion
We find DHEA to be an effective treatment for midlife-onset major and minor
depression. Source: Schmidt et.
al Arch Gen Psychiatry. 2005;62:154-162.
see full
abstract cached abstract
Service de Medecine Interne Generale, Hopital Erasme, U.L.B.
...recent studies confirmed positive effects of DHEA administration in
healthy elderly people, mostly more than 70 years old women, on skin, bone
density, muscle strength and several neuropsychological symptoms. Positive
effects on sexual interest and satisfaction and sense of well-being are more
consistent in elderly women than in men. The recommended administered dose
is 25 mg to 50 mg once a day in women and 100 mg in men.
see full abstract
cached abstract
Clinical uses and misuses of
dehydroepiandrosterone. Curr Opin
Pharmacol. 2003 Dec;3(6):635-41. Review.
....Evidence is accruing in support of dehydroepiandrosterone
supplementation in adrenal insufficiency, hypopituitarism, osteoporosis,
systemic lupus erythematosus, depression and schizophrenia. ...
Double-blind treatment of major
depression with dehydroepiandrosterone.
Wolkowitz OM, Reus VI, Keebler A, Nelson N, Friedland M, Brizendine L,
Roberts E.
Department of Psychiatry, University of California Medical Center, San
Francisco, USA.
CONCLUSIONS: These results suggest that DHEA treatment may
have significant antidepressant effects in some patients with major
depression. Further, larger-scale trials are warranted.